col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


37 Ergebisse       Seite 1

 [1] 
Elsevier: Diabetes & Metabolism
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Dez―09 Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020-2021 Yann Brousse, Patrick Gérardin, Dina Filali, Victorine Lenclume, Hind Aissaoui, Marie-Christine Jaffar Bandjee, et al. (+2)
2 [GO] 2024―Dez―06 Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France Anthony Albouy, Céline Lambert, Pierre Bernard, Catherine Laporte, Frédéric Fortin
3 [GO] 2023―Jan―17 Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study Anne-Sophie MARIET, Jean-Michel PETIT, Eric BENZENINE, Catherine QUANTIN, Benjamin BOUILLET
4 [GO] 2022―Mai―31 Protection by metformin against severe Covid-19: an in-depth mechanistic analysis Nicolas Wiernsperger, Abdallah Al-Salameh, Bertrand Cariou, Jean-Daniel Lalau
5 [GO] 2022―Apr―21 Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study Anda-Petronela Radan, Mihaela-Madalina Fluri, Konstantinos Nirgianakis, Beatrice Mosimann, Bettina Schlatter, Luigi Raio, Daniel Surbek
6 [GO] 2022―Mrz―09 Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism? Hironobu Sasaki, Arata Itoh, Hiroshi Itoh
7 [GO] 2022―Jan―25 Fulminant type 1 diabetes after COVID-19 vaccination Xiaohan Tang, Binbin He, Zhenqi Liu, Zhiguang Zhou, Xia Li
8 [GO] 2022―Jan―10 Variable incidence of ketoacidosis in youth with type 1 diabetes onset during Covid-19 pandemic peaks in France Juliette Delpeut, Elisa Giani, Dalila Louet, Marc de Kerdanet, Carine Choleau, Jacques Beltrand
9 [GO] 2021―Dez―01 Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: propensity score analysis of a territory-wide cohort in Hong Kong Carlos K.H. Wong, David T.W. Lui, Angel Y.C. Lui, Ashley C.Y. Kwok, Marshall C.H. Low, Kristy T.K. Lau, et al. (+5)
10 [GO] 2021―Nov―12 Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine Christophe Masset, Sabine Lebot-Bouras, Julien Branchereau, Karine Renaudin, Diego Cantarovich
11 [GO] 2021―Okt―25 The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation Abdallah Al-Salameh, Youssef Bennis, Bertrand Cariou, Jean-Daniel Lalau
12 [GO] 2021―Okt―25 Statin use in patients with diabetes amid COVID-19 pandemic Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
13 [GO] 2021―Jul―29 Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19 Luigi Di Filippo, Rebecca De Lorenzo, Clara Sciorati, Annalisa Capobianco, Nicola I. Lorè, Andrea Giustina, et al. (+3)
14 [GO] 2021―Jul―28 Diabetic ketoacidosis and mortality in COVID-19 infection J.S. Stevens, M.M. Bogun, D.J. McMahon, J. Zucker, P. Kurlansky, S. Mohan, et al. (+3)
15 [GO] 2021―Mrz―26 ASSOCIATION OF HYPERGLYCAEMIA WITH HOSPITAL MORTALITY IN NONDIABETIC COVID-19 PATIENTS: A COHORT STUDY M. Mamtani, A.M. Athavale, M. Abraham, J. Vernik, A.R. Amarah, J.P. Ruiz, et al. (+7)
16 [GO] 2021―Jan―27 Diabetes is not associated with COVID-19-related mortality in older institutionalized people Pauline Legris, Laurence Vaillard, Christine Nonciaux, Philippe Hourdain, Mickaël Taroux, Jean-Michel Petit, et al. (+2)
17 [GO] 2020―Dez―31 Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort Willy Sutter, Baptiste Duceau, Maxime Vignac, Guillaume Bonnet, Aurélie Carlier, Ronan Roussel, et al. (+24)
18 [GO] 2020―Dez―23 Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies André J. Scheen
19 [GO] 2020―Dez―10 Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19 Jean-Daniel Lalau, Abdallah Al-Salameh, Samy Hadjadj, Thomas Goronflot, Nicolas Wiernsperger, Matthieu Pichelin, et al. (+27)
20 [GO] 2020―Nov―26 DPP-4 inhibition and COVID-19: From initial concerns to recent expectations André J. Scheen
21 [GO] 2020―Nov―05 Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19? Jun Young Do, Sang Won Kim, Jong Won Park, Kyu Hyang Cho, Seok Hui Kang
22 [GO] 2020―Okt―28 Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes Thirunavukkarasu Sathish, Robyn J. Tapp, Mark E. Cooper, Paul Zimmet
23 [GO] 2020―Okt―19 Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: Results from the CORONADO study Bertrand Cariou, Thomas Goronflot, Antoine Rimbert, Sandrine Boullu, Cédric Le May, Philippe Moulin, et al. (+8)
24 [GO] 2020―Okt―15 Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study L. Ghesquière, C. Garabedian, E. Drumez, M. Lemaître, M. Cazaubiel, C. Bengler, A. Vambergue
25 [GO] 2020―Sep―04 Elevated fasting blood glucose at admission is associated with poor outcomes in patients with COVID-19 Shuyi Liu, Bin Zhang, Jingjing You, Luyan Chen, Huanchu Yuan, Shuixing Zhang
26 [GO] 2020―Aug―01 Metformin and COVID-19: From cellular mechanisms to reduced mortality André J. Scheen
27 [GO] 2020―Jul―29 Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection Sarra Smati, Pascale Mahot Moreau, Alexandre Bourdiol, Stéphane Ploteau, Samy Hadjadj, Bertand Cariou
28 [GO] 2020―Jul―29 Body Mass Index and Outcome in Patients with COVID-19: A Dose-Response Meta-Analysis Raymond Pranata, Michael Anthonius Lim, Emir Yonas, Rachel Vania, Antonia Anna Lukito, Bambang Budi Siswanto, Markus Meyer
29 [GO] 2020―Jun―17 SGLT2 inhibition during the COVID-19 epidemic: friend or foe? André J. Scheen
30 [GO] 2020―Jun―16 Lifestyle changes in patients with morbid obesity and type 2 diabetes mellitus during the COVID-19 pandemic Michał Wysocki, Maciej Walędziak, Monila Proczko-Stepaniak, Michał Pędziwiatr, Jacek Szeliga, Piotr Major
31 [GO] 2020―Jun―04 Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19 Giovanni Targher, Alessandro Mantovani, Christopher D. Byrne, Xiao-Bo Wang, Hua-Dong Yan, Qing-Feng Sun, et al. (+6)
32 [GO] 2020―Mai―28 Towards individualized and optimalized positioning of non-ventilated COVID-19 patients: Putting the affected parts of the lung(s) on top? Sébastien Froelich, Emmanuel Mandonnet, Jean-Baptiste Julla, Cyril Touchard, Marie Laloi-Michelin, Jean-Philippe Kevorkian, Jean-François Gautier
33 [GO] 2020―Mai―21 Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients Raffaele Marfella, Pasquale Paolisso, Celestino Sardu, Luca Bergamaschi, Emanuela Concetta D’Angelo, Michelangela Barbieri, et al. (+9)
34 [GO] 2020―Mai―21 COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes L Potier, J B Julla, R Roussel, P Boudou, D C Gauthier, C Ketfi, J F Gautier
35 [GO] 2020―Mai―21 Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports André J. Scheen, Michel Marre, Charles Thivolet
36 [GO] 2020―Mai―13 Patients with diabetes are at higher risk for severe illness from COVID-19 Giovanni Targher, Alessandro Mantovani, Xiao-Bo Wang, Hua-Dong Yan, Qing-Feng Sun, Ke-Hua Pan, et al. (+6)
37 [GO] 2020―Mai―06 Three alternative ways to screen for hyperglycaemia in pregnancy during the COVID-19 pandemic A. Vambergue, S. Jacqueminet, M.-F. Lamotte, F. Lamiche-Lorenzini, C. Brunet, P. Deruelle, et al. (+2)
 [1] 

37 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.074 sec